SPOTLIGHT: Lilly settles 900 more Zyprexa claims

Eli Lilly has settled some 900 lawsuits over its antipsychotic drug Zyprexa, including five set to go to trial next month, leaving about 1,100 claims unsettled. Many of the plaintiffs alleged that Lilly downplayed the drug's side effects, including weight gain and elevated blood sugar. The company has set aside $1.2 billion to cover the claims. Report | Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.